A Real-World Observational Study: Zevorcabtagene Autoleucel Injection in Patients with Relapsed/Refractory Multiple Myeloma
Clinical trial NCT06659770 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06659770
- Sponsor
- CARsgen Therapeutics Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-10-01
- Primary completion
- 2027-12-31
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.